NUVECTIS PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.54 USD | -3.40% |
|
+5.31% | -21.58% |
Chart calendar Nuvectis Pharma, Inc.
c35708cfc98535ed.D8WGyKo3lbOoovKcKyT-MD1_RWhCuI0LaUWWXXHb8yY.dry0kZ5l1_Kbj4T-QGbHAlggERAFgdVTXw__EhiJn182sNeFx0fChOHwuw~05b14e228d3cfe88eccf1d53bd4dabac
Upcoming events on Nuvectis Pharma, Inc.
Past events on Nuvectis Pharma, Inc.
| 20/05/2024 09:30 pm | H.C. Wainwright BioConnect Investor Conference - Fireside Chat |
| 07/05/2024 05:30 pm | Q1 2024 Earnings Release |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Predictive Biomarkers 6 |
| 09/04/2024 02:00 am | American Association for Cancer Research Meeting - First-in-Human Phase I Clinical Trials 1 |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Novel Targets and Pathways |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Cell Cycle, Transcription Regulation, and Antican |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Kinase and Phosphatase Inhibitors 1 |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - NXP900, a novel YES1/SRC |
| 19/03/2024 08:30 pm | Roth Conference |
| 05/03/2024 06:30 pm | Q4 2023 Earnings Release |
| 02/03/2024 12:30 am | Neaux Cancer Oncology Conference |
| 13/02/2024 08:30 pm | Oppenheimer Healthcare Life Sciences Conference |
| 09/01/2024 06:00 am | JPMorgan Healthcare Conference |
| 17/11/2023 06:00 am | AACR Special Conference - Ramez N. Eskander |
| 08/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 15/10/2023 01:30 am | AACR-NCI-EORTC International Conference |
| 13/10/2023 10:00 pm | AACR-NCI-EORTC International Conference - NXP800 |
| 13/10/2023 10:00 pm | AACR-NCI-EORTC International Conference - NXP900 |
| 06/10/2023 07:20 pm | AACR Special Conference |
| 26/09/2023 09:55 pm | Cantor Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -12,9 -14,2 9.2% | -19,2 -18,5 -3.97% | -22,9 -22,5 -1.76% | -25,0 |
|
EBIT Million USD | Released Forecast Spread | -12,9 -14,2 9.2% | -19,2 -18,1 -6.52% | -22,9 -22,4 -2.1% | -24,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,9 -14,2 9.23% | -19,1 -18,0 -6.12% | -22,3 -21,9 -1.53% | -24,0 |
|
Net income Million USD | Released Forecast Spread | -12,9 -14,2 9.23% | -19,1 -18,0 -6.1% | -22,3 -21,9 -1.53% | -24,0 |
|
EPS USD | Released Forecast Spread | -3,02 -3,39 10.91% | -1,51 -1,41 -7.09% | -1,43 -1,42 -0.47% | -1,29 |
| Announcement Date | 22/03/22 | 08/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -2,95 -2,80 -5.18% | -3,57 -3,40 -5.09% | -5,94 -3,80 -56.26% | -6,78 -6,10 -11.11% | -5,77 -6,00 3.8% | -6,16 -6,10 -0.95% | -6,87 -6,50 -5.63% | -4,40 -7,00 37.2% | -5,40 | -7,20 | -8,00 | |
|
EBIT Million USD | Released Forecast Spread | -2,95 -2,80 -5.18% | -3,57 -3,25 -10.07% | -5,94 -3,79 -56.74% | -6,78 -5,38 -26% | -4,10 -7,46 45% | -5,77 -4,51 -27.95% | -6,16 -5,97 -3.21% | -6,87 -6,36 -7.96% | -4,40 -7,21 39.02% | -6,01 | -6,22 | -6,49 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,94 -2,80 -5.11% | -3,57 -3,25 -9.95% | -5,88 -3,78 -55.46% | -6,70 -5,59 -19.74% | -4,05 -7,36 44.96% | -5,71 -4,43 -28.73% | -5,88 -5,96 1.27% | -6,62 -6,29 -5.35% | -4,17 -6,96 40.06% | -5,69 | -6,43 | -6,82 |
|
Net income Million USD | Released Forecast Spread | -2,94 -2,80 -5.11% | -3,57 -3,25 -9.95% | -5,88 -3,78 -55.46% | -6,70 -5,59 -19.74% | -4,05 -7,08 42.79% | -5,71 -4,43 -28.73% | -5,88 -5,96 1.27% | -6,62 -6,29 -5.35% | -4,17 -6,96 40.06% | -5,69 | -6,43 | -6,82 |
|
EPS USD | Released Forecast Spread | -0,32 -0,22 -45.45% | -0,28 -0,24 -16.67% | -0,42 -0,27 -55.56% | -0,48 -0,39 -24.14% | -0,27 -0,45 40% | -0,38 -0,21 -80.95% | -0,37 -0,34 -7.77% | -0,41 -0,39 -6.03% | -0,25 -0,40 36.71% | -0,31 | -0,34 | -0,34 |
| Announcement Date | 12/05/22 | 10/08/22 | 08/11/22 | 08/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 05/03/24 | 07/05/24 | - | - | - |
More events
Past sector events for Nuvectis Pharma, Inc.
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 05:30 pm | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVCT Stock
- Calendar Nuvectis Pharma, Inc.
